share_log

THC Biomed Intl Ltd. (OTCMKTS:THCBF) Short Interest Down 89.1% in January

Financial News Live ·  Jan 16, 2023 14:01

THC Biomed Intl Ltd. (OTCMKTS:THCBF – Get Rating) was the recipient of a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 6,100 shares, a drop of 89.1% from the December 31st total of 56,200 shares. Based on an average daily trading volume, of 39,100 shares, the days-to-cover ratio is currently 0.2 days.

THC Biomed Intl Price Performance

Shares of OTCMKTS:THCBF traded up $0.00 during trading on Monday, hitting $0.02. 4,600 shares of the stock were exchanged, compared to its average volume of 20,487. THC Biomed Intl has a 1-year low of $0.01 and a 1-year high of $0.08. The company's fifty day simple moving average is $0.02 and its 200-day simple moving average is $0.03.

Get THC Biomed Intl alerts:

THC Biomed Intl Company Profile

(Get Rating)

THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.

Read More

  • Get a free copy of the StockNews.com research report on THC Biomed Intl (THCBF)
  • 4 High-Yield Dividend Kings For 2023
  • Will 2023 be a Good Year for Goodyear Tire Stock?
  • Lululemon Stock, Buying Opportunity on Lowered Guidance?
  • Is Delta On Track To Hit A Fresh 52-Week High?
  • Should You Add These Warren Buffett Stocks to Your Portfolio?

Receive News & Ratings for THC Biomed Intl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for THC Biomed Intl and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment